BRIEF-Merus And Biohaven Announce Collaboration To Co-Develop Three Novel Bispecific ADC Programs

Reuters

13 Jan

Jan 12 (Reuters) - Merus NV 2GH.F:

MERUS AND BIOHAVEN ANNOUNCE COLLABORATION TO CO-DEVELOP THREE NOVEL BISPECIFIC ADC PROGRAMS
BIOHAVEN LTD - CO IS RESPONSIBLE FOR PRECLINICAL ADC GENERATION OF THREE MERUS BISPECIFIC ANTIBODIES UNDER MUTUALLY AGREED RESEARCH PLANS
BIOHAVEN - AGREEMENT INCLUDES TWO MERUS BISPECIFIC PROGRAMS GENERATED USING BICLONICS PLATFORM
BIOHAVEN LTD - MERUS WILL RECEIVE AN UPFRONT PAYMENT AND LICENSE FEE AT ADC CANDIDATE NOMINATION OF FIRST PROGRAM

Source text: ID:nGNX47y28G

Further company coverage: 2GH.F

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2503319806"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2503319806\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2503319806?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-13 09:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503319806","market":"us","top_or_hot":-1,"title":"BRIEF-Merus And Biohaven Announce Collaboration To Co-Develop Three Novel Bispecific ADC Programs","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Merus And Biohaven Announce Collaboration To Co-Develop Three Novel Bispecific ADC Programs</title></head><body><p><span>Jan 12 (Reuters)</span><span> - </span>Merus NV <span>2GH.F</span>:</p><ul><li><p>MERUS AND BIOHAVEN ANNOUNCE COLLABORATION TO CO-DEVELOP THREE NOVEL BISPECIFIC ADC PROGRAMS</p></li><li><p>BIOHAVEN LTD - CO IS RESPONSIBLE FOR PRECLINICAL ADC GENERATION OF THREE MERUS BISPECIFIC ANTIBODIES UNDER MUTUALLY AGREED RESEARCH PLANS</p></li><li><p>BIOHAVEN - AGREEMENT INCLUDES TWO MERUS BISPECIFIC PROGRAMS GENERATED USING BICLONICS PLATFORM</p></li><li><p>BIOHAVEN LTD - MERUS WILL RECEIVE AN UPFRONT PAYMENT AND LICENSE FEE AT ADC CANDIDATE NOMINATION OF FIRST PROGRAM</p></li></ul><p>Source text: <span>ID:nGNX47y28G</span></p><p>Further company coverage: <span>2GH.F</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Merus And Biohaven Announce Collaboration To Co-Develop Three Novel Bispecific ADC Programs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Merus And Biohaven Announce Collaboration To Co-Develop Three Novel Bispecific ADC Programs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-01-13 09:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Merus And Biohaven Announce Collaboration To Co-Develop Three Novel Bispecific ADC Programs</title></head><body><p><span>Jan 12 (Reuters)</span><span> - </span>Merus NV <span>2GH.F</span>:</p><ul><li><p>MERUS AND BIOHAVEN ANNOUNCE COLLABORATION TO CO-DEVELOP THREE NOVEL BISPECIFIC ADC PROGRAMS</p></li><li><p>BIOHAVEN LTD - CO IS RESPONSIBLE FOR PRECLINICAL ADC GENERATION OF THREE MERUS BISPECIFIC ANTIBODIES UNDER MUTUALLY AGREED RESEARCH PLANS</p></li><li><p>BIOHAVEN - AGREEMENT INCLUDES TWO MERUS BISPECIFIC PROGRAMS GENERATED USING BICLONICS PLATFORM</p></li><li><p>BIOHAVEN LTD - MERUS WILL RECEIVE AN UPFRONT PAYMENT AND LICENSE FEE AT ADC CANDIDATE NOMINATION OF FIRST PROGRAM</p></li></ul><p>Source text: <span>ID:nGNX47y28G</span></p><p>Further company coverage: <span>2GH.F</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BHVN","symbol_name":"Biohaven Pharmaceutical Holding Co Ltd.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUA6PLL82:1","article_id":"2503319806","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503319806","pubTimestamp":1736730495,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Merus And Biohaven Announce Collaboration To Co-Develop Three Novel Bispecific ADC ProgramsJan 12 (Reuters) - Merus NV 2GH.F:MERUS AND BIOHAVEN ANNOUNCE COLLABORATION TO CO-DEVELOP THREE NOVEL B","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BHVN":"Biohaven Pharmaceutical Holding Co Ltd.","BK4139":"生物科技","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1"},"translate_title":"简介-Merus和Biohaven宣布合作共同开发三个新型双特异性ADC项目","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BHVN":0.9},"content_text":"BRIEF-Merus And Biohaven Announce Collaboration To Co-Develop Three Novel Bispecific ADC ProgramsJan 12 (Reuters) - Merus NV 2GH.F:MERUS AND BIOHAVEN ANNOUNCE COLLABORATION TO CO-DEVELOP THREE NOVEL BISPECIFIC ADC PROGRAMSBIOHAVEN LTD - CO IS RESPONSIBLE FOR PRECLINICAL ADC GENERATION OF THREE MERUS BISPECIFIC ANTIBODIES UNDER MUTUALLY AGREED RESEARCH PLANSBIOHAVEN - AGREEMENT INCLUDES TWO MERUS BISPECIFIC PROGRAMS GENERATED USING BICLONICS PLATFORMBIOHAVEN LTD - MERUS WILL RECEIVE AN UPFRONT PAYMENT AND LICENSE FEE AT ADC CANDIDATE NOMINATION OF FIRST PROGRAMSource text: ID:nGNX47y28GFurther company coverage: 2GH.F ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."

Consult now
Download APP
Scan QR code to download the app.